share_log

Eloxx Pharmaceuticals Q2 EPS $(1.96) Misses $(1.54) Estimate

Eloxx Pharmaceuticals Q2 EPS $(1.96) Misses $(1.54) Estimate

Eloxx Pharmicals 第二季度每股收益 (1.96) 未达到预期 (1.54)
Benzinga ·  2023/08/14 08:43

Eloxx Pharmaceuticals (NASDAQ:ELOX) reported quarterly losses of $(1.96) per share which missed the analyst consensus estimate of $(1.54) by 27.27 percent. This is a 1533.33 percent decrease over losses of $(0.12) per share from the same period last year.

Eloxx Pharmicals(纳斯达克股票代码:ELOX)公布的季度每股亏损为1.96美元,比分析师普遍预期的1.54美元(1.54美元)低27.27%。这比去年同期的每股亏损(0.12美元)减少了1533.33%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发